The Brutalist Report

MarketWatch

• Moody’s says a recession will be hard to avoid if oil prices stay elevated for even a few more weeks [36d]
• U.S. stocks have been surprisingly resilient as the Iran conflict threatens global economic disruption. Thank industry analysts? [36d]
• Upstart’s stock rises as analyst says investors have been ignoring a key catalyst [36d]
• Warren Buffett’s parting gift to Berkshire Hathaway: A $2 billion Iran oil windfall [36d]
• Elon Musk’s xAI is facing a growing number of lawsuits over AI-generated deepfakes [36d]
• The stock market actually doesn’t care as much about oil prices as you think [36d]
• A picture of a retirement plan is worth a thousand words [36d]
• Trump says ‘numerous countries’ will help reopen the Strait of Hormuz but declines to name them [36d]
• The U.S. dollar and crypto are both benefiting from the Iran crisis, in an unusual move [36d]
• Why some Facebook and Instagram advertisers are freaking out about a new payment policy [36d]
• These stocks are cheaper ways to invest in Palantir’s success [36d]
• Here’s how much more U.S. drivers are paying at the pump as the Iran conflict enters a third week [36d]
• Strategy’s stock has soared 35% off its February low, more than doubling bitcoin’s gain [36d]
• Medicare premiums could double over next the decade, sabotaging retirement budgets [36d]
• Record Oscar haul for Warner Bros. caps off a topsy-turvy year for the legendary studio [36d]
• Tesla’s stock rises as investors embrace ambitious foray into making AI chips [36d]
• Micron’s stock climbs, putting a big milestone in sight [36d]
• Chinese stocks could fall by up to 10% if Trump-Xi summit is delayed, Morgan Stanley strategists say [36d]
• I’m 37 and won a settlement. I maxed out my IRA. How do I invest the $21,000 I have left? [36d]
• How Intuit is reacting to a stock price that it deems ‘meaningfully misaligned’ with reality [37d]
• Will Meta really cut 20% of its staff — and is AI to blame? [37d]
• Strategist provides a formula for how long the Iran war lasts [37d]
• Higher prices help Dollar Tree grow sales faster than its top rival [37d]
• This biotech is working on an GLP-1 drug that could be better than the Wegovy pill [37d]
• The IRS has changed the tax rules for 2026 — here’s how to keep more money and not overpay [37d]